Speakers

Natasha is one of the physiologist leads for echo services in Warrington and Halton Hospitals in the Northwest of England. She has a research interest in 3D assessment of aortic stenosis and champions the development of physiologist led services.

Aortic stenosis: Grading severity of low-flow AS

The assessment of aortic stenosis is straight forward under normal flow conditions when all the pieces of the puzzle slot together in the same category. But what happens when the flow conditions change and the parameters become discordant?

A practical approach to assessing a stenotic valve in the presence of a low flow state and when to ask for further tests.

Head of the Congenital Echo department at Leeds teaching Hospitals providing echo assessment of the fetus, child and adult with suspected congenital heart disease (CHD). She is currently leading the BSE Congenital Echo accreditation which aims to improve standards of echocardiography in children and adults with CHD. She is also a Fellow of the BSE.

Left heart obstruction

This presentation will provide a practical guide to assessing left heart obstruction in patients with congenital heart disease.

Dr Arjun K Ghosh MBBS MSc PhD FHEA FACC FESC FRCP FICOS is the first cardiologist in the UK to be appointed specifically in cardio-oncology and helped establish Cardio-Oncology services at both these hospitals which are now amongst the biggest services worldwide. Arjun leads the cardio-oncology service at UCLH and is joint first author of the first British (BSE-BCOS) cardio-oncology guidelines published earlier this year.

Sarah Hudson is a final year cardiology registrar based at the Bristol Heart Institute with an interest in advanced echocardiography.

Twitter

Hani is a Committee member of the EACVI/Education and HIT 2020-2022. He has previously been the EACVI Training grant winner, Echocardiography Lab, Royal Brompton Hospital, London, UK as well as Past Clinical Fellow, Cardiovascular Imaging, Queen Elizabeth Hospital, University Hospitals Birmingham, NHS Foundation Trust. His main interests are advanced echocardiography, 3D-TTE, 3D-TOE and interventional TOE during structural cardiac interventions.

Mitral valve prolapse: Diagnosis and added value of 3D echo

We should not be liberal in diagnosing MVP, It is not a good thing for the patient to have. Sticking to the parasternal long axis view can let you miss prolapse of other medial or lateral scallops. so long as the term prolapse is restricted to indicate superior displacement of free margin of leaflet above the annular plane, the shape of the annulus is irrelevant”. We should not forget to assess the duration of regurgitation before grading the severity of MR.

3D Echocardiography is superior to 2D Echocardiography in terms of determining the Location and extension of the prolapse, quantitative assessment of MVP and assessment of annular dynamics.

Liam is a consultant cardiologist at the West Suffolk Hospital in Suffolk. He has an interest in advanced echocardiography and valve disease. He has contributed to a number of recent BSE guidelines and was the first author for the recently published aortic stenosis guideline, and joint first author for the normal reference intervals guideline. He is also passionate about teaching echo.

Assessment of endocarditis

A review of the echocardiographic assessment of patient with suspected or confirmed endocarditis. This encompasses the step wise assessment of the valves and other myocardial structures that may be affected by IE, and a review of potential complications of IE. It will also outline the link between important echocardiographic findings and management decision in IE.

Anjana is a Consultant Cardiologist and head of echo at QAH, a busy DHG performing over 16,000 echos per year. She has trained a number of physiologists in TOE and stress echo and established physiologist led services for each. Physiologist led contrast and valve clinics are also established as routine. Anjana is clinical lead for pulmonary hypertension servies at QAH running monthly clinics in conjunction with Hammersmith hospital PH team.

Rick is Clinical Lead for Cardiovascular Imaging at UHB, incorporating multimodality approaches using echocardiography, magnetic resonance and nuclear imaging. He is a past President of the British Society of Echocardiography, and current member of the BSE Research Group. He is an Honorary Reader at the Institute of Cardiovascular Sciences, University of Birmingham, and has published extensively in the field.

Twitter

Assessment of cardiac masses

Cardiac masses are rare, but are an important component of cardiovascular imaging. The differential lies in clinical practice between thrombus, infection and tumours, which will be touched on in this lecture. The advent of multimodality imaging has enabled identification of the etiology of cardiac masses in many cases, especially in conjunction with information from clinical settings. Many now believe that CMR is required for diagnosis – but careful and thoughtful echocardiography will deliver on the day in most cases.

Kelly is a clinical scientist with TTE and TOE accreditation. She is the lead for echocardiography at Cleveland Clinic London. Kelly has completed a doctorate in clinical science. Her interests lie in structural valve intervention. She is the BSE communications committee chair and the lead author of the (yet to be released) BSE aortic regurgitation guideline.

Twitter

Aortic regurgitation: Grading severity in complex cases

This presentation will confirm your suspicions: assessing aortic regurgitation is not always as easy as we may have thought. In this session we will recap the commonly used qualitative, semi-qualitative and quantitative approaches applied in the assessment of aortic regurgitation. The strengths as well as pitfalls of these techniques will be examined. We will also discuss the secondary pathologies associated with aortic regurgitation, what it means when we are approaching surgical thresholds and differences in chronic reverses acute aortic regurgitation. We will also look at the value of newer, less well understood approaches in the assessment of aortic regurgitation severity. Finally we will look at what we do when we are still stuck in terms of determining severity and if other cardiac imaging modalities provide any additional benefits.